SO
SomnoMed Limited
SOMNF · OTC
$0.45 -0.00% (-$0.00)
Market Cap $138.2M
P/E Ratio -
Div. Yield -
ROE 5.54%
Bulios Fair Price
$0.3
33.3% downside
Current Price
$0.45
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SOMNF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
50 /100
Fair EV/EBITDA 19.60x
P/S 1.21x
P/B 2.92x
Growth
77 /100
Growing Rev. growth 11.01%
Book val. growth 28.32%
EPS growth N/A
Profitability
31 /100
Weak Gross margin 53.18%
Net margin 2.31%
Op. margin 0.85%
Quality
38 /100
Average ROIC 10.46%
ROE 5.54%
ROA 3.53%
Debt
83 /100
Low Debt/Equity 0.12x
Current ratio 1.67x
Int. coverage 2.10x
Stability
67 /100
Stable Beta 0.80x
Rev. volatility 9.64%
EPS volatility 44.02%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SOMNF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Karen Borg
Employees
461
Headquarters
Crows Nest
Upcoming events
26 FEB
Earnings
Upcoming earnings report